Olayinka Opeoluwa, Gnanaraj Jerome, Khaliq Waseem
Department of Medicine, Johns Hopkins Bayview Medical Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Womens Health Rep (New Rochelle). 2022 Sep 13;3(1):768-773. doi: 10.1089/whr.2022.0014. eCollection 2022.
Despite the proven mortality benefit of screening colonoscopy, ∼27% of hospitalized women are nonadherent with colorectal cancer (CRC) screening guidelines. Colonoscopy is the most frequently used test for CRC screening in the United States. Although CRC is the second most common cause of cancer death in the United States, CRC screening has not been part of usual hospital care.
This study explores how hospitalized women perceive value of inpatient screening colonoscopy by evaluating the mean amount of money that hospitalized women are willing to contribute toward the cost of a screening colonoscopy during a hospital stay.
A cross-sectional bedside survey consisting of a contingent valuation questionnaire was used to assess the contribution these women considered to be justified for the convenience of an inpatient screening colonoscopy. The probit regression model was used for the analysis of contingent valuation data to predict mean willingness to pay toward inpatient screening colonoscopy.
Of the 312 enrolled patients, 48% were willing to pay a mean of $171.56 (95% confidence interval [CI] $37.59-$305.54, = 0.012) in advance toward the cost of an inpatient screening colonoscopy. After adjustment of possible sociodemographic and clinical covariates that could impact willingness to contribute, hospitalized women were willing to pay a mean of $178.41 (95% CI $40.67-$316.16, = 0.011).
The findings of this study suggest that hospitalized women value the prospect of screening colonoscopy during hospitalization. Offering screening colonoscopy to nonadherent hospitalized women, especially those who are at high risk for developing CRC, may improve adherence among hospitalized women.
This study is registered at www.clinicaltrials.gov (NCT04162925).
尽管结肠镜筛查已被证实可降低死亡率，但约27%的住院女性未遵守结直肠癌（CRC）筛查指南。在美国，结肠镜检查是CRC筛查最常用的检测方法。尽管CRC是美国癌症死亡的第二大常见原因，但CRC筛查尚未成为常规医院护理的一部分。
本研究通过评估住院女性在住院期间愿意为筛查结肠镜检查费用贡献的平均金额，探讨她们如何看待住院期间筛查结肠镜检查的价值。
采用一项包含或有估值问卷的横断面床边调查，以评估这些女性认为因住院筛查结肠镜检查的便利性而合理的贡献金额。使用概率回归模型分析或有估值数据，以预测对住院筛查结肠镜检查的平均支付意愿。
在312名登记患者中，48%的人愿意预先支付平均171.56美元（95%置信区间[CI]为37.59美元至305.54美元，P = 0.012）用于住院筛查结肠镜检查的费用。在调整可能影响贡献意愿的社会人口统计学和临床协变量后，住院女性愿意支付的平均金额为178.41美元（95% CI为40.67美元至316.16美元，P = 0.011）。
本研究结果表明，住院女性重视住院期间筛查结肠镜检查的前景。为未遵守筛查的住院女性，尤其是那些患CRC风险较高的女性提供筛查结肠镜检查，可能会提高住院女性的筛查依从性。
